Hot off the Forge
-
“That mission has brought together an incredible group of scientists and partners who believe, as we do, that children with…
-
“Providing a new visual restoration treatment option for patients living with retinitis pigmentosa is central to our mission,” said Yusaku…
-
Under the partnership, Forge is providing Skylark with process development, current good manufacturing practice (cGMP) manufacturing, and analytical development services.
-
“At ASGCT, we’re proud to showcase how our FUEL™ platform is enabling more doses per batch, improving scalability for broader…
-
Epicrispr Biotechnologies and Forge announce a strategic partnership to support the development and manufacturing of EPI-321.
-
“Forge Biologics has set a powerful example of sustainability and scientific excellence advancing together.”
-
“The era of Progeria gene therapy has arrived. Our hope is that SamPro-2 will give children and young adults with…
-
Ascidian and Forge announce a strategic partnership to advance the development and manufacturing of ACDN-01, Ascidian’s lead retinal program for…
-
“Forge’s AAV-specific manufacturing expertise and platform technologies give us confidence in a smooth path forward in the development of AVST-101,”…
-
Fractyl Health will leverage Forge’s FUEL™ platform to manufacture AAV for Rejuva, Fractyl’s pancreatic gene therapy platform for patients with…
-
Oral and poster presentations will highlight data demonstrating the enhanced productivity, recovery, and consistent quality of Forge’s FUEL™ AAV manufacturing…
-
“We’re proud to support Affinia’s vision of bringing hope to patients affected by cardiomyopathy through their innovative gene therapy.”
ESCGT 2026 Annual Congress
Bringing together experts, researchers, and professionals in gene and cell therapy.